Cyclophosphamide for Rapid-Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome
Patients with rapid-onset obesity, hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and neural crest tumor syndrome have poor long-term outcomes. We report a patient who was treated successfully with high-dose cyclophosphamide immunoablation. This experience offers a novel therapeutic approach and an indirect insight into the underlying pathogenesis of this syndrome.
OMA, Opsoclonus myoclonus ataxia, ROHHAD, Rapid onset of obesity, hypothalamic dysfunction, hypoventilation, autonomic dysregulation
To access this article, please choose from the options below
I.P.-P. is a St. Baldrick's Foundation Scholar. The authors declare no conflicts of interest.
PII: S0022-3476(10)00584-6
doi:10.1016/j.jpeds.2010.07.006
© 2011 Mosby, Inc. All rights reserved.
